GlassScriptPhysician profile
Edra C Hewitt
NPI 1700861739
$3,456.65
in general payments reported to CMS, 2019-2025
16 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $20.41 · 2021: $318 · 2022: $401 · 2023: $500 · 2024: $516 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,282.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $815.09 | 2019-2025 | Dupixent |
| Genzyme Corporation | $584.31 | 2021-2025 | |
| Aerin Medical INC. | $461.09 | 2019-2025 | |
| Medtronic, INC. | $428.81 | 2023-2025 | Stealthstation S8 Platform, Propel |
| Glaxosmithkline, LLC. | $377.60 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $223.39 | 2019-2021 | |
| Stryker Corporation | $168.99 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $109.92 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $77.11 | 2024 | Inspire |
| Alk-Abello, INC | $66.35 | 2019 | |
| Optinose US, INC. | $44.97 | 2019-2023 | |
| Hikma Pharmaceuticals USA | $24.80 | 2025 | Ryaltris |
| Lilly USA, LLC | $20.73 | 2025 | Zepbound |
| Checkpoint Surgical, INC | $19.45 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.80 | 2025 | Xhance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edra Hewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.